Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.

[1]  Silvia Muro,et al.  Endothelial targeting of antibody-decorated polymeric filomicelles. , 2011, ACS nano.

[2]  V. Muzykantov,et al.  Catalase and Superoxide Dismutase Conjugated with Platelet-Endothelial Cell Adhesion Molecule Antibody Distinctly Alleviate Abnormal Endothelial Permeability Caused by Exogenous Reactive Oxygen Species and Vascular Endothelial Growth Factor , 2011, Journal of Pharmacology and Experimental Therapeutics.

[3]  G. Molema,et al.  Liposome‐encapsulated dexamethasone attenuates ventilator‐induced lung inflammation , 2011, British journal of pharmacology.

[4]  Z. Suntres,et al.  Protective Effects of Liposomal N-Acetylcysteine against Paraquat-Induced Cytotoxicity and Gene Expression , 2011, Journal of toxicology.

[5]  A. Fakhari,et al.  Controlling ligand surface density optimizes nanoparticle binding to ICAM-1. , 2011, Journal of pharmaceutical sciences.

[6]  D. Speicher,et al.  Peroxiredoxin 6 Phosphorylation and Subsequent Phospholipase A2 Activity Are Required for Agonist-mediated Activation of NADPH Oxidase in Mouse Pulmonary Microvascular Endothelium and Alveolar Macrophages* , 2011, The Journal of Biological Chemistry.

[7]  W. Arap,et al.  Targeting neuropilin-1 in human leukemia and lymphoma. , 2011, Blood.

[8]  V. Muzykantov,et al.  PECAM‐targeted delivery of SOD inhibits endothelial inflammatory response , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Robert J Levy,et al.  Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[10]  B. Moeller,et al.  Combinatorial vascular targeting in translational medicine , 2010, Proteomics. Clinical applications.

[11]  J. Schnitzer,et al.  Lung Vascular Targeting Using Antibody to Aminopeptidase P: CT-SPECT Imaging, Biodistribution and Pharmacokinetic Analysis , 2010, Journal of Vascular Research.

[12]  Wadih Arap,et al.  Combinatorial ligand-directed lung targeting. , 2009, Proceedings of the American Thoracic Society.

[13]  J. Schnitzer,et al.  Targeting and imaging signature caveolar molecules in lungs. , 2009, Proceedings of the American Thoracic Society.

[14]  C. Berkland,et al.  ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  R. Frey,et al.  NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. , 2009, Antioxidants & redox signaling.

[16]  K. Birukov,et al.  Oxidized phospholipids in control of inflammation and endothelial barrier , 2009, Translational Research.

[17]  P. Witting,et al.  Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. , 2008, Antioxidants & redox signaling.

[18]  Samir Mitragotri,et al.  Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  A. Malik,et al.  Regulation of Endothelial Junctional Permeability , 2008, Annals of the New York Academy of Sciences.

[20]  R. Albrecht,et al.  Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia-reperfusion injury of the lung in vivo. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[21]  A. Vachani,et al.  Dietary flaxseed supplementation ameliorates inflammation and oxidative tissue damage in experimental models of acute lung injury in mice. , 2006, The Journal of nutrition.

[22]  V. Muzykantov,et al.  Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature. , 2005, Blood.

[23]  A. Fisher,et al.  Activation of endothelial NADPH oxidase during normoxic lung ischemia is KATP channel dependent. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[24]  A. Fisher,et al.  Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. , 2005, Free radical biology & medicine.

[25]  C. Dodia,et al.  Lysosomal-type PLA2 and turnover of alveolar DPPC. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[26]  V. Muzykantov.  Targeting of superoxide dismutase and catalase to vascular endothelium. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[27]  V. Muzykantov,et al.  Cell‐selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  V. Muzykantov.  Delivery of antioxidant enzyme proteins to the lung. , 2001, Antioxidants & redox signaling.

[29]  D. Curiel,et al.  A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  B. Babior.  The NADPH Oxidase of Endothelial Cells , 2000, IUBMB life.

[31]  P. Shek,et al.  Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. , 2000, Surgery.

[32]  V. Muzykantov,et al.  Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Dodia,et al.  Role of phospholipase A2 enzymes in degradation of dipalmitoylphosphatidylcholine by granular pneumocytes. , 1996, Journal of lipid research.

[34]  E. Moase,et al.  Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. , 1995, Biochimica et biophysica acta.

[35]  A. Al-Mehdi,et al.  A phospholipase A2 inhibitor decreases generation of thiobarbituric acid reactive substance during lung ischemia-reperfusion. , 1993, Biochimica et biophysica acta.

[36]  C. Dodia,et al.  A competitive inhibitor of phospholipase A2 decreases surfactant phosphatidylcholine degradation by the rat lung. , 1992, The Biochemical journal.

[37]  O. Jones,et al.  The superoxide-generating NADPH oxidase of human neutrophils is electrogenic and associated with an H+ channel. , 1987, The Biochemical journal.

[38]  A. Kabanov,et al.  Cross-linked antioxidant nanozymes for improved delivery to CNS. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[39]  V. Muzykantov,et al.  Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies. , 2008, Biomaterials.

[40]  V. Muzykantov,et al.  Targeted delivery of therapeutics to endothelium , 2008, Cell and Tissue Research.

[41]  W. Arap,et al.  Vascular targeting and antigen presentation , 2001, Nature Immunology.

[42]  V. Muzykantov,et al.  Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress. , 1998, The American journal of physiology.

[43]  O. Berg,et al.  Kinetic basis for interfacial catalysis by phospholipase A2. , 1995, Methods in enzymology.